HK1208148A1 - 增强治療急性卒中之抗血小板藥物之遞送方法及其組合物 - Google Patents

增强治療急性卒中之抗血小板藥物之遞送方法及其組合物

Info

Publication number
HK1208148A1
HK1208148A1 HK15107716.1A HK15107716A HK1208148A1 HK 1208148 A1 HK1208148 A1 HK 1208148A1 HK 15107716 A HK15107716 A HK 15107716A HK 1208148 A1 HK1208148 A1 HK 1208148A1
Authority
HK
Hong Kong
Prior art keywords
enhancing
delivery
treatment
composition
acute stroke
Prior art date
Application number
HK15107716.1A
Other languages
English (en)
Inventor
林仁政林俊杰李旭东樊裕明蔡瑞骐
Original Assignee
Lin Jen Cheng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lin Jen Cheng filed Critical Lin Jen Cheng
Publication of HK1208148A1 publication Critical patent/HK1208148A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK15107716.1A 2013-07-29 2015-08-10 增强治療急性卒中之抗血小板藥物之遞送方法及其組合物 HK1208148A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW102127167A TW201503900A (zh) 2013-07-29 2013-07-29 增強治療急性中風之抗血小板藥物之遞送方法及其組合物

Publications (1)

Publication Number Publication Date
HK1208148A1 true HK1208148A1 (zh) 2016-02-26

Family

ID=52495124

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107716.1A HK1208148A1 (zh) 2013-07-29 2015-08-10 增强治療急性卒中之抗血小板藥物之遞送方法及其組合物

Country Status (4)

Country Link
US (2) US20150064238A1 (zh)
CN (2) CN113713100A (zh)
HK (1) HK1208148A1 (zh)
TW (1) TW201503900A (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018053052A1 (en) 2016-09-13 2018-03-22 Rasna Research Inc. Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275812A (en) * 1985-06-07 1994-01-04 The General Hospital Corporation Method of treatment for myocardial infarction
EP1093814A1 (en) * 1999-10-22 2001-04-25 Boehringer Ingelheim Pharma KG Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
RU2006143838A (ru) * 2004-05-13 2008-06-20 БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) Применение дипиридамола для лечения устойчивости к ингибиторам тромбоцитов
US20070112414A1 (en) 2005-09-08 2007-05-17 Conor Medsystems, Inc. System and method for local delivery of antithrombotics
CN1969912A (zh) * 2005-11-23 2007-05-30 北京奇源益德药物研究所 治疗心脑血管疾病的药物组合物及其制备方法和质控方法
MX2011010390A (es) * 2009-03-30 2011-12-14 Cerulean Pharma Inc Conjugados, particulas, composiciones de agentes polimericos y metodos relacionados de uso.
CA2812063A1 (en) * 2010-08-30 2012-06-07 President And Fellows Of Harvard College Shear controlled release for stenotic lesions and thrombolytic therapies

Also Published As

Publication number Publication date
US20180289814A1 (en) 2018-10-11
CN113713100A (zh) 2021-11-30
TWI492758B (zh) 2015-07-21
US11660345B2 (en) 2023-05-30
US20150064238A1 (en) 2015-03-05
TW201503900A (zh) 2015-02-01
CN104338137A (zh) 2015-02-11

Similar Documents

Publication Publication Date Title
HK1215378A1 (zh) 藥物組合物、治療方法及其用途
HK1222398A1 (zh) 治療伯克霍爾德氏菌感染症的組合物及方法
EP2991953A4 (en) COMPOSITION FOR TREATING STONE AND METHOD FOR MANUFACTURING THE SAME
GB201320723D0 (en) Composition and methods of treatment
SG11201509782TA (en) Compositions and methods for the treatment of diabetes and pre-diabetes
GB201305414D0 (en) Method and composition
HK1208378A1 (zh) 用於治療真菌感染的新的藥物組合物
EA033123B9 (ru) Антипролиферативная и антиметастатическая фармацевтическая композиция и способ лечения рака
ZA201703398B (en) Pharmaceutical composition and methods
HK1219691A1 (zh) 醫藥組成物及其用途
HK1220374A1 (zh) 用於治療碳氧血紅蛋白血症的組合物和方法
GB201406172D0 (en) Therapy and pharmaceutical composition
HK1214767A1 (zh) 片劑形式的藥物組合物及其製造方法
GB201307082D0 (en) Pharmaceutical composition comprising 15-HETrE and methods of using the same
HK1217715A1 (zh) 治療中風的組合物及方法
HK1208148A1 (zh) 增强治療急性卒中之抗血小板藥物之遞送方法及其組合物
HRP20181933T1 (hr) Farmaceutski postupak i intermedijari
EP2941248A4 (en) COMPOSITION AND METHOD FOR TREATING BODY SURFACE
GB201518882D0 (en) Agrochemical composition and method of use thereof
GB201310349D0 (en) Composition and method of use thereof
GB201301928D0 (en) Composition and method of use thereof